US$ 20.47
glp 1 drugs for weight loss Patients' Use GLP-1 Loss, Benefit Gains Americans Need More Information About
Description
Orforglipron, a nonpeptide GLP-1 RA administered once daily, showed dose-dependent efficacy on weight loss in a Phase II trial

Its a natural hormone your body makes in the gut that helps control blood sugar, appetite and digestion

For cardiovascular risk reduction, it is only approved for adults over the age of 18

De Block CE, De Leeuw IH, Pelckmans PA, et al

doi: 10.1161/01.cir.0000437739.71477.ee

The findings, which showed that these events were rare but significant, particularly in patients using the drugs for weight loss, were published in the Journal of the American Medical Association (JAMA)
